Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Medicine
Volume 2009, Article ID 170735, 6 pages
Case Report

Liquorice Health Check, Oro-Dental Implications, and a Case Report

Department of Periodontics Faculty of Dentistry, McGill University, 3640 University Street, Montreal, QC, Canada H3Y 2B2

Received 16 April 2009; Accepted 11 June 2009

Academic Editor: Mohammad Abdollahi

Copyright © 2009 Louis Z. G. Touyz. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Brown, in Encyclopaedia of Herbs and Their Uses, vol. 289, pp. 283–284, RD Press, Montreal, Canada, 1995.
  2. A. Olukoga and D. Donaldson, “Liquorice and its health implications,” Journal of the Royal Society for the Promotion of Health, vol. 120, no. 2, pp. 83–89, 2000. View at Google Scholar
  3. S. Budavari, Ed., Chemical Formulations. Glycyrrhizin-4515. Cyclamate-2770; Saccharin-8463, Merck & Co, Rahway, NJ, USA, 12th edition, 1996, The Merck Index.
  4. M. Quinkler and P. M. Stewart, “Hypertension and the cortisol-cortisone shuttle,” The Journal of Clinical Endocrinology & Metabolism, vol. 88, no. 6, pp. 2384–2392, 2003. View at Google Scholar
  5. J. Snow, “Glycyrrhiza glabra. Monograph,” Protocol Journal of Botanical Medicine, vol. 1, no. 3, pp. 9–14, 1996. View at Google Scholar
  6. S. K. Acharya, S. Dasarathy, A. Tandon, Y. K. Joshi, and B. N. Tandon, “A preliminary open trial on interferon stimulator (SNMC) derived from Glycyrrhiza glabra in the treatment of subacute hepatic failure,” Indian Journal of Medical Research, vol. 98, pp. 69–74, 1993. View at Google Scholar
  7. Y. Arase, K. Ikeda, N. Murashima et al., “The long term efficacy of glycyrrhizin in chronic hepatitis C patients,” Cancer, vol. 79, no. 8, pp. 1494–1500, 1997. View at Publisher · View at Google Scholar
  8. T. G. J. Van Rossum, A. G. Vulto, W. C. J. Hop, J. T. Brouwer, H. G. M. Niesters, and S. W. Schalm, “Intravenous glycyrrhizin for the treatment of chronic hepatitis C: a double-blind, randomized, placebo-controlled phase I/II trial,” Journal of Gastroenterology and Hepatology, vol. 14, no. 11, pp. 1093–1099, 1999. View at Publisher · View at Google Scholar
  9. T. G. J. Van Rossum, A. G. Vulto, W. C. J. Hop, and S. W. Schalm, “Glycyrrhizin-induced reduction of ALT in European patients with chronic hepatitis C,” American Journal of Gastroenterology, vol. 96, no. 8, pp. 2432–2437, 2001. View at Publisher · View at Google Scholar
  10. R. V. Farese Jr., E. G. Biglieri, C. H. L. Shackleton, I. Irony, and R. Gomez-Fontes, “Licorice-induced hypermineralocorticoidism,” The New England Journal of Medicine, vol. 325, no. 17, pp. 1223–1227, 1991. View at Google Scholar
  11. M. Rotblatt and I. Zimenr, “Liquorice,” in Evidence Based Herbal Medicine, pp. 252–258, Hanley & Belfus, Philadelphia, Pa, USA, 2002. View at Google Scholar
  12. Risk and safety assessment on the consumption of Locorice root (Glycyrrhiza sp.) its extract and powder as a food ingredient, March 2007.
  13. F. Aoki, K. Nakagawa, M. Kitano et al., “Clinical safety of Licorice Flavonoid Oil (LFO) and pharmacokinetics of glabridin in healthy humans,” Journal of the American College of Nutrition, vol. 26, no. 3, pp. 209–218, 2007. View at Google Scholar
  14. H. Á. Sigurjónsdóttir, L. Franzson, K. Manhem, J. Ragnarsson, G. Sigurdsson, and S. Wallerstedt, “Liquorice-induced rise in blood pressure: a linear dose-response relationship,” Journal of Human Hypertension, vol. 15, no. 8, pp. 549–552, 2001. View at Publisher · View at Google Scholar
  15. W. B. Kannel, “Fifty years of Framingham Study contributions to understanding hypertension,” Journal of Human Hypertension, vol. 14, no. 2, pp. 83–90, 2000. View at Google Scholar
  16. L. Adam, “In vitro antiviral activity of indigenous glycyrrhizin, liquorice and glycyrrhizic acid (Sigma) on Japanese encephalitis virus,” Journal of Communication Disorders, vol. 29, no. 2, pp. 91–99, 1997. View at Google Scholar
  17. J. Cinatl, B. Morgenstern, G. Bauer, P. Chandra, H. Rabenau, and H. W. Doerr, “Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus,” The Lancet, vol. 361, no. 9374, pp. 2045–2046, 2003. View at Publisher · View at Google Scholar
  18. T. Hattori, S. Ikematsu, A. Koito et al., “Preliminary evidence for inhibitory effect of glycyrrhizin on HIV replication in patients with AIDS,” Antiviral Research, vol. 11, no. 5-6, pp. 255–262, 1989. View at Google Scholar
  19. J. G. Chung, “Inhibitory actions of glycyrrhizic acid on arylamine N-acetyl transferase of Helicobacter pylori from peptic ulcer patients,” Drug and Chemical Toxicology, vol. 21, no. 3, pp. 355–370, 1998. View at Google Scholar
  20. W. D. W. Rees, J. Rhodes, and J. E. Wright, “Effect of deglycyrrhizinated liquorice on gastric mucosal damage by aspirin,” Scandinavian Journal of Gastroenterology, vol. 14, no. 5, pp. 605–607, 1979. View at Google Scholar
  21. F. Borrelli and A. A. Izzo, “The plant kingdom as a source of anti-ulcer remedies,” Phytotherapy Research, vol. 14, no. 8, pp. 581–591, 2000. View at Publisher · View at Google Scholar
  22. S. Shintani, H. Murase, H. Tsukagoshi, and T. Shiigai, “Glycyrrhizin (licorice)-induced hypokalemic myopathy: report of 2 cases and review of the literature,” European Neurology, vol. 32, no. 1, pp. 44–51, 1992. View at Google Scholar
  23. V. E. Tyler, Herbs of Choice: The Therapeutic Use of Phytomedicinals, Pharmaceutical Press, Binghamton, NY, USA, 1994.
  24. S. Shibata, “A drug over the millennia: pharmacognosy, chemistry, and pharmacology of licorice,” Yakugaku Zasshi, vol. 120, no. 10, pp. 849–862, 2000. View at Google Scholar
  25. M. Abdollahi, R. Rahimi, and M. Radfar, “Current opinion on drug-induced oral reactions: a comprehensive review,” Journal of Contemporary Dental Practice, vol. 9, no. 3, pp. 1–15, 2008. View at Google Scholar
  26. K. Atilla and R. S. Vasan, “Prehypertension and risk of cardiovascular disease,” Expert Review of Cardiovascular Therapy, vol. 4, no. 1, pp. 111–117, 2006. View at Publisher · View at Google Scholar
  27. S. Saydah, M. Eberhardt, N. Rios-Burrows, D. Williams, L. Geiss, and R. Dorsey, “Prevalence of chronic kidney disease and associated risk factors—United States, 1999–2004,” Morbidity and Mortality Weekly Report, vol. 56, no. 8, pp. 161–165, 2007. View at Google Scholar
  28. K. L. Ong, B. M. Y. Cheung, Y. B. Man, C. P. Lau, and K. S. L. Lam, “Prevalence, awareness, treatment, and control of hypertension among United States adults 1999–2004,” Hypertension, vol. 49, no. 1, pp. 69–75, 2007. View at Publisher · View at Google Scholar
  29. J. Moore, “Hypertension: catching the silent killer,” The Nurse Practitioner, vol. 30, no. 10, pp. 16–18, 2005. View at Google Scholar
  30. N. Mumoli and M. Cei, “Licorice-induced hypokalemia,” International Journal of Cardiology, vol. 124, no. 3, pp. e42–e44, 2008. View at Publisher · View at Google Scholar
  31. S. H. van Uum, “Liquorice and hypertension,” The Netherlands Journal of Medicine, vol. 63, no. 4, pp. 119–120, 2005. View at Google Scholar
  32. S. Russo, M. Mastropasqua, M. A. Mosetti, C. Persegani, and A. Paggi, “Low doses of liquorice can induce hypertension encephalopathy,” American Journal of Nephrology, vol. 20, no. 2, pp. 145–148, 2000. View at Google Scholar
  33. T. Saito, Y. Tsuboi, G. Fujisawa et al., “An autopsy case of licorice-induced hypokalemic rhabdomyolysis associated with acute renal failure: special reference to profound calcium deposition in skeletal and cardiac muscle,” Nippon Jinzo Gakkai Shi, vol. 36, no. 11, pp. 1308–1314, 1994. View at Google Scholar
  34. T. Breidthardt, M. Namdar, and B. Hess, “A hypertensive urgency induced by the continuous intake of a herbal remedy containing liquorice,” Journal of Human Hypertension, vol. 20, no. 6, pp. 465–466, 2006. View at Publisher · View at Google Scholar
  35. G. J. de Klerk, M. G. Nieuwenhuis, and J. J. Beutler, “Hypokalaemia and hypertension associated with use of liquorice flavoured chewing gum,” British Medical Journal, vol. 314, no. 7082, pp. 731–732, 1997. View at Google Scholar
  36. R. G. Dluhy, B. Anderson, B. Harlin, J. Ingelfinger, and R. Lifton, “Glucocorticoid-remediable aldosteronism is associated with severe hypertension in early childhood,” Journal of Pediatrics, vol. 138, no. 5, pp. 715–720, 2001. View at Publisher · View at Google Scholar
  37. R. P. Lifton, “Genetic dissection of human blood pressure variation: common pathways from rare phenotypes,” Harvey Lectures, vol. 100, pp. 71–101, 2004. View at Google Scholar
  38. D. Armanini, L. Calò, and A. Semplicini, “Pseudohyperaldosteronism: pathogenetic mechanisms,” Critical Reviews in Clinical Laboratory Sciences, vol. 40, no. 3, pp. 295–335, 2003. View at Google Scholar
  39. B. Sontia, J. Mooney, L. Gaudet, and R. M. Touyz, “Pseudohyperaldosteronism, liquorice, and hypertension,” The Journal of Clinical Hypertension, vol. 10, no. 2, pp. 1–5, 2008. View at Google Scholar
  40. L. Z. G. Touyz, “Liquorice, hypertension and the dentist,” The Journal of the Canadian Dental Association, vol. 73, no. 6, pp. 467–468, 2007. View at Google Scholar
  41. J. Vaya, P. A. Belinky, and M. Aviram, “Antioxidant constituents from liquorice roots: structure elucidation and anti-oxidative capacity towards LDL oxidation,” Free Radical Biology & Medicine, vol. 23, no. 2, pp. 302–313, 1997. View at Google Scholar